AllCells Granted Tissue Bank License

EMERYVILLE, Calif.--(BUSINESS WIRE)--AllCells, LLC, a leading global provider of human primary cells and related services for the life science industry today announced the State of California Health and Human Services Agency has granted a Tissue Bank License to the company’s Emeryville, CA facilities. The license enables AllCells to engage in the operation of a tissue bank in accordance with Division 2, Chapter 4.1 of the Health and Safety Code.

“An important element of our growth strategy involves seeking collaborations with companies looking for a reliable supply of hematopoietic tissue, including stem/progenitor cells, for their cell-based therapy projects”

“AllCells can now consider opportunities to provide human hematological tissue for various clinical applications such as cell therapy, regenerative and personalized medicine, thereby expanding potential market applications for our products,” explained Jay Tong MD, the company’s founder and CEO.

“We’re leveraging the capabilities of our clinical operations division to serve markets beyond in-vitro research use which is what many of our customers have been asking for,” commented Wayne Vaz, the company’s VP of Corporate & Business Development. “An important element of our growth strategy involves seeking collaborations with companies looking for a reliable supply of hematopoietic tissue, including stem/progenitor cells, for their cell-based therapy projects,” added Mr. Vaz.

About AllCells, LLC

AllCells (www.AllCells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements.